BIXTBIOXYTRAN, INC同业对比
BIOXYTRAN, INC 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BIXT本股 | — | — | — | — | -22.5%#6 | 10.3%#9 | -964.3%#7 | — | — | — | — | — |
| BDRX | $318.4B#1 | — | — | — | — | — | — | — | — | — | -95.9%#5 | — |
| BEIGF | — | — | — | — | 40.2%#4 | 144.5%#2 | 8.4%#2 | 5.5%#1 | 29.9%#1 | 6#2 | — | — |
| BGM | — | — | — | — | 51.1%#2 | -1282.1%#11 | -33.2%#4 | -5.1%#2 | — | — | -96.3%#6 | — |
| BHST | $55M#4 | — | 2.2x#1 | 1.6x#1 | 37.0%#5 | 13.8%#8 | -16.2%#3 | -43.8%#5 | -216.8%#2 | — | -69.2%#4 | — |
| BIOE | — | — | — | — | 485.8%#1 | 168.5%#1 | 47.4%#1 | — | — | 8#1 | — | — |
| BIOM | — | — | — | — | — | 16.6%#7 | — | — | — | — | — | — |
| BLRX | $7.1B#2 | — | 391.7x#3 | 6040.3x#2 | -95.9%#7 | 78.0%#4 | -871.8%#6 | -11.1%#4 | — | — | -24.8%#2 | — |
| BLTE | $6.4B#3 | — | 8.4x#2 | — | — | -114.7%#10 | — | -10.1%#3 | — | — | 133.9%#1 | — |
| BQST | — | — | — | — | — | 64.7%#5 | — | — | — | — | — | — |
| BSPK | — | — | — | — | 42.3%#3 | 30.0%#6 | -89.0%#5 | — | — | — | — | — |
| BYSI | $36M#5 | — | — | — | — | 91.0%#3 | — | — | — | — | -55.8%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-08-09。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议